Brainomix’s e-Stroke software was recently deployed across University Hospitals Sussex NHS Foundation Trust, with the software now live at Royal Sussex County Hospital in Brighton, Worthing Hospital, and at St Richard’s Hospital in Chichester. The trust is one of the largest acute trusts in the UK, covering West Sussex, Brighton and Hove, and parts of East Sussex, hosting more than 1.5 million outpatient appointments, A&E visits and surgical cases each year.
“In line with the trust’s mission to deliver excellent care every time, we are always looking to implement the latest technology to support our clinicians and patients,” noted Oliver Phillips, Director of Strategy & Planning, University Hospitals Sussex. “For stroke, working with Brainomix on their e-Stroke platform has been a great opportunity to deliver innovative care for our patients in line with our vision and clinical strategy. The team at Brainomix have been excellent to work with, taking a proactive and collaborative approach.”
The Sussex Integrated Stroke Delivery Network has driven the roll out of the software as part of its system-wide working across Sussex Health and Care Partnership and the plan is for this to be further rolled out across the ICS footprint.
Dr Ingrid Kane, a Consultant Stroke Physician at Royal Sussex County Hospital, spoke about the value that e-Stroke will bring to the Trust’s stroke service. “At a local level, this decision support tool will help us to speed up diagnosis and therefore patient care in a simple and safe way. From a Sussex perspective the implementation of Brainomix across the region will support the highly specialized thrombectomy pathway, facilitating the timely transfer of those eligible for treatment to the specialist hubs. For both patients and clinicians having access to this support, no matter where they live in Sussex, is a real step forward for stroke care.”
The roll-out of e-Stroke in the region is part of a larger project resulting from a prestigious NHSX AI award to Brainomix in September 2020, enabling the company to deploy its software across five UK stroke networks to assess its “real world” impact on patient care.
Brainomix is a partner of the National Consortium of Intelligent Medical Imaging (NCIMI), a strategic network of NHS hospitals, clinical leaders, industry experts, world-leading researchers, and patient groups, with a focus on driving innovation in the UK’s AI sector. Its CEO, Dr. Claire Bloomfield, spoke about the role NCIMI is playing in supporting Brainomix’s NHSX AI programme: “NCIMI are delighted to continue our successful and long-standing collaboration with Brainomix to expand the use of stroke AI into the clinical pathway at University Hospitals Sussex. This is part of a wider regional multi-centered initiative to deliver improved patient outcomes and to generate new insights and learning for the NHS – both about AI adoption challenges in general and the specifics of integrating AI into the stroke care pathway.”